COLLA, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 309
AS - Asia 186
EU - Europa 24
SA - Sud America 11
AF - Africa 7
OC - Oceania 1
Totale 538
Nazione #
US - Stati Uniti d'America 304
SG - Singapore 77
CN - Cina 53
TR - Turchia 30
HK - Hong Kong 11
BR - Brasile 10
IN - India 5
IT - Italia 5
MX - Messico 4
PL - Polonia 4
SE - Svezia 4
ZA - Sudafrica 4
DE - Germania 3
ES - Italia 2
JP - Giappone 2
KE - Kenya 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
FI - Finlandia 1
FR - Francia 1
GB - Regno Unito 1
ID - Indonesia 1
IQ - Iraq 1
KR - Corea 1
MA - Marocco 1
TH - Thailandia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 538
Città #
Dallas 154
Santa Clara 37
Singapore 19
Hong Kong 11
Ashburn 10
Shanghai 9
Los Angeles 6
West Jordan 6
Guangzhou 5
Laurel 5
Assago 4
Johannesburg 4
Stockholm 4
Warsaw 4
Baltimore 3
Jinhua 3
Phoenix 3
Seattle 3
Shenzhen 3
São Paulo 3
The Dalles 3
Beijing 2
Boca Raton 2
Boston 2
Brooklyn 2
Chicago 2
Frankfurt am Main 2
Istanbul 2
Jiaxing 2
Jiujiang 2
Mexico City 2
Mumbai 2
New York 2
San Francisco 2
San Jose 2
Tokyo 2
Almirante Tamandaré 1
Amsterdam 1
Baghdad 1
Bangkok 1
Belo Horizonte 1
Berrechid 1
Brasília 1
Buffalo 1
Carney 1
Caruaru 1
Cedar Knolls 1
Central City 1
Chennai 1
Clifton 1
Foshan 1
Helsinki 1
Hurst 1
Hyderabad 1
Jakarta 1
Kent 1
Kintnersville 1
Lagoa do Tocantins 1
Long An 1
Melbourne 1
Mexicali 1
Mississauga 1
Montebello 1
Moore 1
Nairobi 1
Oakland 1
Oklahoma City 1
Paris 1
Parobé 1
Pasadena 1
Pinellas Park 1
Pune 1
Punta Gorda 1
Quanzhou 1
Raleigh 1
Reston 1
Rotherham 1
Rui'an 1
Salt Lake City 1
San Nicolás de los Garza 1
Sanming 1
Secaucus 1
Seoul 1
Sumaré 1
Taizhou 1
Tashkent 1
Thika 1
Waltham 1
Wuxi 1
Xuzhou 1
Zapala 1
Totale 384
Nome #
The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice 120
Two-way arginine transport in human endothelial cells: TNF-alpha stimulation is restricted to system y(+) 22
Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease. 19
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 18
Subcellular localization of alpha-synuclein aggregates and their interaction with membranes 18
TonEBP is inhibited by RNA helicase A via interaction involving the E ' F loop 17
DNA-dependent protein kinase (DNA-PK) and Ataxia-Telengiectasia Mutated (ATM) protect cells from hypertonic stress by activating TonEBP transcriptional activator 17
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 17
Nuclear localization signal of TonEBP is regulated by changes in tonicity 17
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy 17
Accumulation of Toxic alpha-Synuclein Oligomer within Endoplasmic Reticulum Occurs in alpha-Synucleinopathy In Vivo 16
Linking the endoplasmic reticulum to Parkinson’s disease and alpha-synucleinopathy 16
Endoplasmic reticulum stress is associated with alpha-synucleinopathy in transgenic mice model 16
Microbiome, Parkinson's Disease and Molecular Mimicry 15
Endoplasmic Reticulum Stress Is Important for the Manifestations of alpha-Synucleinopathy In Vivo 15
Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy 15
Toxic alpha-synuclein oligomer accumulation and endoplasmic reticulum stress is mechanistically linked to alpha-synucleinopathy in vivo 15
Alpha-synuclein fret biosensors reveal early alpha-synuclein aggregation in the endoplasmic reticulum 15
Novel nuclear localization signal regulated by ambient tonicity in vertebrates 15
Exogenous administration of microsomes-associated alpha-synuclein aggregates to primary neurons as a powerful cell model of fibrils formation 14
SYNUCLEIN DEPENDENT NEURODEGENERATION AND NEUROPROTECTION IN VIVO: IMPLICATIONS FOR PATHOGENESIS OF PARKINSON'S DISEASE 14
Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD 14
Alpha-Synuclein and Parkinson’s Disease Motor and Non-Motor Symptoms: what is new? 14
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 13
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 13
Multiple domains of TonEBP cooperate to stimulate transcription in response to hypertonicity 12
LPS and TNF alpha increase arginine transport and CAT-2 expression in cultured human endothelial cells 12
DNA-dependent protein kinase (DNA-PK) phosphorylates and activates TonEBP/NFAT5 in response to hypertonicity 12
RNA helicase a modulates activity of TonEBP/NFAT5 transcriptional activator in hypertonicity 12
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations 11
LPS and TNF alpha increase arginine transport but not nitric oxide production in cultured human endothelial cells 11
Totale 572
Categoria #
all - tutte 6.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.427


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202494 0 0 0 0 0 2 0 46 2 7 4 33
2024/2025245 22 40 24 2 4 32 33 12 20 2 13 41
2025/2026233 63 119 51 0 0 0 0 0 0 0 0 0
Totale 572